Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
3500 participants
INTERVENTIONAL
2022-07-12
2025-07-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Artificial Intelligence Confocal Laser Endomicroscopy for Real-time Assessment of Gastric Cancer Risk.
NCT05459428
Automatic Evaluation of the Extent of Intestinal Metaplasia With Artificial Intelligence
NCT05459610
a Prospective Study on the Efficacy of Magnifying Endoscopy With Narrow-band Imaging in Diagnosing Gastric Lesions
NCT01508520
OLGA Stage is More Appropriate in Predicting Early Gastric Cancer
NCT02562976
Application of Linked Color Imaging（LCI） in Diagnosis of Early Gastric Cancer(EGC)
NCT03661671
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SCREENING
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Kimura-Takemoto classification
Kimura-Takemoto classification
All patients were given two risk scores, the order of which was randomly determined.
EGGIM
EGGIM
All patients were given two risk scores, the order of which was randomly determined.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Kimura-Takemoto classification
All patients were given two risk scores, the order of which was randomly determined.
EGGIM
All patients were given two risk scores, the order of which was randomly determined.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients intend to undergo ESD treatment
Exclusion Criteria
* Patients with previous surgical procedures on the stomach
* patients with contraindications to biopsy
* Patients who refuse to sign the informed consent form.
40 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Yanqing Li
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yanqing Li
Vice President of Qilu Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Qilu Hospital, Shandong University
Jinan, Shandong, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-SDU-QILU-120
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.